• Home
• People
  • Management
  • Scientific Advisors
  • Clinical Advisors
• Technology
• Product Pipeline
  • Vaccines
  • Tumor Immunotherapy
  • Precision Immunization™
• Presentations
• Publications
• News
• Intellectual Property
• About MultimericBio
  • Company
  • Investors
• Contact

Investors

Multimeric Biotherapeutics, Inc. is a Delaware C corporation funded by its founders, Angel investors, and NIH grants. It is currently seeking additional Angel investors and first round funding.

Interested investors are invited to contact:

Marc Hertz, Ph.D
Chief Executive Officer
mherz{at}multimericbio.com